Key result
Cardiac macrophage heterogeneity suggests novel therapeutic targets to prevent post-MI heart failure.
Why the study?
Maladaptive ventricular remodelling and heart failure after AMI remain challenging, and non-specific strategies have failed, prompting a need to understand emerging heterogeneity in cardiac monocyte and macrophage biology.
Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Challenges traditional M1/M2 models; hypothesis-generating for subset-specific therapies to prevent post-MI heart failure.
Peet et al. (2019) studied this question. Emerging evidence reveals heterogeneity in cardiac macrophage populations, suggesting novel therapeutic targets could prevent heart failure after myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: